Works in Cancer Chemotherapy & Pharmacology, 2005, Vol 56, Issue 4

Results: 15

Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 400, doi. 10.1007/s00280-005-1029-9

By:

Jiajun Liu;
Huiling Lu;
Renwei Huang;
Dongjun Lin;
Xiangyuan Wu;
Qu Lin;
Xinyao Wu;
Jing Zheng;
Xianglin Pan;
Jun Peng;
Yuqin Song;
Maohong Zhang;
Ming Hou;
Feng Chen

Publication type:

Article

Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 415, doi. 10.1007/s00280-005-1016-1

By:

Boccardo, Francesco;
Rubagotti, Alessandra;
Conti, Giario;
Potenzoni, Domenico;
Manganelli, Antonio;
del Monaco, Demetrio

Publication type:

Article

Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 370, doi. 10.1007/s00280-005-1005-4

By:

de Jonge, Milly E.;
Huitema, Alwin D. R.;
Holtkamp, Marjo J.;
van Dam, Selma M.;
Beijnen, Jos H.;
Rodenhuis, Sjoerd

Publication type:

Article

Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 361, doi. 10.1007/s00280-005-1026-z

By:

Bruno, Rene;
Washington, Carla B.;
Jian-Feng Lu;
Lieberman, Grazyna;
Banken, Ludger;
Klein, Pamela

Publication type:

Article

Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2).

Published in:

2005

By:

Mohrmann, Karin;
Eijndhoven, Maria A. J.;
Schinkel, Alfred H.;
Schellens, Jan H. M.;
van Eijndhoven, Maria A J

Publication type:

journal article

Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 379, doi. 10.1007/s00280-005-1019-y

By:

Ting-Chao Chou;
Yongbiao Guan;
Soenen, Danielle R.;
Danishefsky, Samuel J.;
Boger, Dale L.

Publication type:

Article

Identification of biliary metabolites of ifosfamide using <sup>31</sup>P magnetic resonance spectroscopy and mass spectrometry.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 409, doi. 10.1007/s00280-005-1023-2

By:

Payne, Geoffrey S.;
Dzik-Jurasz, Andrzej S. K.;
Mancini, Laura;
Nutley, Bernard;
Raynaud, Florence;
Leach, Martin O.

Publication type:

Article

Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 358, doi. 10.1007/s00280-005-1031-2

By:

Pappas, Periklis;
Karavasilis, Vasilis;
Briasoulis, Evangelos;
Pavlidis, Nicholas;
Marselos, Marios

Publication type:

Article

Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 391, doi. 10.1007/s00280-004-0953-4

By:

Jamieson, S. M. F.;
Liu, J.;
Connor, B.;
McKeage, M. J.

Publication type:

Article

Metabolic profile of XK469 (2( R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug–drug interactions.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 351, doi. 10.1007/s00280-004-0962-3

By:

Anderson, Lawrence W.;
Collins, Jerry M.;
Klecker, Raymond W.;
Katki, Aspandiar G.;
Parchment, Ralph E.;
Boinpally, Ramesh R.;
LoRusso, Patricia M.;
Ivy, S. Percy

Publication type:

Article

Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 337, doi. 10.1007/s00280-004-0987-7

By:

Hess, Suzanne M.;
Mounce, Amanda M.;
Sequeira, Russel C.;
Augustus, Todd M.;
Ackley, Margaret C.;
Bierbach, Ulrich

Publication type:

Article

Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.

Published in:

2005

By:

Desai, Apurva A.;
Kindler, Hedy L.;
Taber, David;
Agamah, Edem;
Mani, Sridhar;
Wade-Oliver, Kurombi;
Ratain, Mark J.;
Vokes, Everett E.

Publication type:

journal article

Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 436, doi. 10.1007/s00280-004-0995-7

By:

Dias, Paulo Fernando;
Siqueira Jr., Jarbas Mota;
Vendruscolo, Luiz Felipe;
de Jesus Neiva, Teresinha;
Gagliardi, Antônio Ricardo;
Maraschin, Marcelo;
Ribeiro-do-Valle, Rosa Maria

Publication type:

Article

Neoadjuvant chemotherapy for epithelial ovarian cancer—role of apoptosis.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 427, doi. 10.1007/s00280-004-0993-9

By:

Dutta, Tania;
Sharma, Himani;
Kumar, Lalit;
Dinda, A. K.;
Kumar, Sunesh;
Bhatla, Neerja;
Singh, Neeta

Publication type:

Article

Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 4, p. 329, doi. 10.1007/s00280-004-0968-x

By:

Kobayashi, Hiroyuki;
Gail Eckhardt, S.;
Lockridge, Jennifer A.;
Rothenberg, Mace L.;
Sandler, Alan B.;
O'Bryant, Cindy L.;
Cooper, Wendy;
Holden, Scott N.;
Aitchison, Roger D.;
Usman, Nassim;
Wolin, Maurice;
Basche, Michele L.

Publication type:

Article